LCTX

Conviction 20HealthcareScan · Mon, Aug 10, 2026

LCTX$1.13+2.73%

ResistanceSupportVol 14

Vol MA14 1.29M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Lineage Cell Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.lineagecell.com ↗

Price1.13

Change+2.73%

Gap+0.00%

Rel volume5.33×

Avg volume1.2M

Avg $ vol1.33M

SMA 201.12

SMA 501.20

SMA 2001.53

Price vs 50-6.07%

Price vs 200-26.23%

MA stackbearish

50/200 cross—

Supertrenddown · 1.22

RSI (14)47

MACD hist0.01

MACD crossbull · 4d

Stoch %K / %D72 / 67

ADX (14)29

+DI / −DI15 / 21

RSI divergence—

MACD divergence—

ATR %+5.20%

ADR %5.08%

52w high1.96

52w low0.9844

From 52w high-42.35%

Above 52w low+14.79%

New 52w highNo

SqueezeOff

Bollinger width18.31%

%B0.57

Donchian pos53.06%

Donchian high1.25

Donchian low1.00

AVWAP (52w high)1.54

vs AVWAP high-26.43%

AVWAP (52w low)1.52

vs AVWAP low-25.90%

OBV trendFlat

Chaikin MF (20)-0.13

Today vs 20d5.33×

Avg vol (14d)1.29M

Avg vol (20d)1.2M

Avg $ vol (20d)1.33M

Market cap285.79M

RS 3m (vs SPY)-25.41%

RS 6m (vs SPY)-48.64%

RS line new highNo

Trend template0/8

Technical rank14.1

1 week+1.80%

1 month-11.72%

3 months-17.52%

6 months-33.53%

1 year+18.85%

YTD-31.10%

P/E-4.50

P/B4.69

P/S19.63

P/FCF-14.70

EPS-0.2800

Div yield—

ROE-104.30%

ROA-59.81%

Debt/Eq—

Current6.61

EV/EBITDA-6.89

Gross margin56.84%

Net margin-436.47%

Rev growth53.24%

EPS growth-241.41%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value248.43M

Revenue1.07M

Net income1.48M

Gross profit1.08M

Free cash flow-19.44M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNYSE

Shares out249.3M

Employees77

ListedThu, Mar 5, 1992

Free float196.6M

Float %78.9%

Short interest29.87M

Days to cover34.6d

Short volume43.6%

Squeeze score73 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank14.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.38

Support1.04

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LCTX

All disclosures →

No recent disclosed trades by Congress in LCTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LCTX

No recent insider (Form 4) filings in LCTX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in LCTX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.